DEVELOPMENT OF FUSION RECOMBINANT PROTEINS BASED ON VP6 AND VP8 OF HUMAN ROTAVIRUS A

Cover Page


Cite item

Full Text

Abstract

Rotaviruses are the most frequent cause of children enteritis. This infection often leads to severe dehydration of organism. Many infectious diseases are accompanied by fluid loss being the most common cause of death. Nowadays an early vaccination is considered to be the most effective way for prevention of rotavirus infection. However attenuated alive vaccines are used for this purpose which can result in different complications. The candidate vaccine presented in this study was designed on the basis of recombinant fusion proteins — the crucial active agents for development of immune response against rotaviruses. As part of the study the following steps were taken: the design of fusion proteins VP6VP8 and FliCVP6VP8; protocol adjustment for induction of genes encoding these proteins expression, which yields in high level of the protein with minor expenditures; production and purification of recombinant proteins VP6VP8 and FliCVP6VP8 with metal affinity chromatography.

About the authors

I. V. Dukhovlinov

Research Institute of Highly Pure Biopreparations, St. Petersburg

Author for correspondence.
Email: fake@neicon.ru
PhD (Biology), Head of the Laboratory of Genetic Engineering of Vaccines, Research Institute of Highly Pure Biopreparations Россия

E. G. Bogomolova

Research Institute of Highly Pure Biopreparations, St. Petersburg

Email: fake@neicon.ru
Junior Researcher, Laboratory of Genetic Engineering of Vaccines, Research Institute of Highly Pure Biopreparations Россия

E. A. Fedorova

Research Institute of Highly Pure Biopreparations, St. Petersburg

Email: fake@neicon.ru
Researcher, Laboratory of Genetic Engineering of Vaccines, Research Institute of Highly Pure Biopreparations Россия

A. S. Simbirtsev

Research Institute of Highly Pure Biopreparations, St. Petersburg

Email: simbirtsev@hpb-spb.com
PhD, MD (Medicine), Director of the Research Institute of Highly Pure Biopreparations Россия

References

  1. Balaram P., Kien P.K., Ismail A. Toll-like receptors and cytokines in immune responses to persistent mycobacterial a 1. nd Salmonella infections. Int. J. Med. Microbiol., 2009, vol. 299, no. 3, pp. 177–185.
  2. Bishop R.F., Davidson G.P., Holmes I.H., RuckB.J. Virus particles in epithelial cells of duodenal mucosa from children with acute non-bacterial gastroenteritis. Lancet 2, 1973, pp. 1281–1283.
  3. Bruijning-Verhagen P., Mangen J.M.-J., Felderhof M., Hartwig G.N., van Houten M., Winkel L., de Waal J.W., Bonten J.M.M. Targeted rotavirus vaccination of high-risk infants; a low cost and highly cost-effective alternative to universal vaccination. BMC Medicine, 2013, vol. 11, p. 112.
  4. Dennehy H.P. Rotavirus Vaccines: an overview. Clin. Microbiol. Rev., 2008, pp. 198–208.
  5. Flewett T.H., Bryden A.S., Davies H.A. Virus particles in gastroenteritis. Lancet, 1973, vol. 302, iss. 7844, p. 1497.
  6. Invitrogen. Ni-NTA purification system. User manual. Catalog nos. K950-01, K951-01, K952-01, K953-01, K954-01, R901-01, R901-10, R 901-15. Version C. 25-0496, 2006, 32 p.
  7. Laemmli U.K. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4. Nature, 1970, vol. 227, pp. 680–685.
  8. Majumder K. Ligation-free gene synthesis by PCR: synthesis and mutagenesis at multiple loci of a chimeric gene encoding OmpA signal peptide and hirudin. Gene, 1992, vol. 110, no. 1, pp. 89–94.
  9. Patton J.T. Rotavirus diversity and evolution in the post-vaccine world. Discovery Med., 2012, vol. 13, no. 68, pp. 85–97.
  10. Schnagl R.D., Holmes I.H. Characteristics of the genome of human infantile enteritis virus (Rotavirus). J. Virol., 1976, vol. 19, no. 1, pp. 267–270.
  11. Studier F.W. Protein production by auto-induction in high density shaking cultures. Protein Expr. Purif., 2005, vol. 41, no. 1, pp. 207–234.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2014 Dukhovlinov I.V., Bogomolova E.G., Fedorova E.A., Simbirtsev A.S.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 64788 от 02.02.2016.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies